{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-081953","form_type":"8-K","ticker":"IOVA","cik":"0001425205","company_name":"IOVANCE BIOTHERAPEUTICS, INC.","filed_at":"2025-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.959572+00:00","generated_at":"2026-05-17T10:32:03.818559+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Iovance Biotherapeutics enters $350M ATM equity offering agreement with Jefferies","bullets":["Agreement with Jefferies LLC to sell up to $350M of common stock in at-the-market offerings.","Jefferies will receive 3.0% commission on gross proceeds from any shares sold.","Sales may be made from time to time at the Company's discretion; no obligation to sell.","Prospectus supplement dated August 22, 2025, filed under existing S-3ASR registration statement.","Agreement is an amendment and restatement of prior open market sale agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-081953","json":"https://secwatch.observer/filing/0001104659-25-081953.json","markdown":"https://secwatch.observer/filing/0001104659-25-081953.md","text":"https://secwatch.observer/filing/0001104659-25-081953.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925081953/0001104659-25-081953-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925081953/tm2524060d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T10:32:03.818559+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}